Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
NCT ID: NCT03014284
Last Updated: 2018-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2017-01-20
2018-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
NCT00268164
The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis
NCT05406882
Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults
NCT00922727
The Effect of Enteral Nutrition Supplemented With Prebiotics on Colonic Microbiota in the Critically Ill Patients
NCT02144168
Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children
NCT01564290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No immune-modulating drug use during study or within 30 days prior to enrollment
* Having colon material collected as part of standard of care
Exclusion Criteria
* Not having colon material collected as part of standard of care
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tyler Curiel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Texas Health Science Center at the Cancer Therapy and Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Therapy & Research Center at UTHSCSA
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC20160555H
Identifier Type: OTHER
Identifier Source: secondary_id
CTMS 16-0101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.